17th November 2021 | Pharma Updates

PM Modi to inaugurate first global summit on pharma sector on Nov 18

The two-day event will be attended by over 40 national and international speakers covering different subjects such as the regulatory environment, funding for innovation and industry-academia.

Carlyle partners with Indian drugmaker Viyash for a generic platform

Dr. Hari Babu and Dr. Srihari Raju Kalidindi, founder and co-founder of Viyash Life Sciences said that CA Hull Investments, an entity of Carlyle and Viyash have set up an integrated generic platform in India.

International Finance Corporation proposes USD 50 mn investment in Hikal

International Finance Corporation is proposing an investment of 50 million dollars in Hikal Limited, an Indian pharmaceutical contract manufacturing company.

IT-OT integration is must for pharma industry 4.O

Leveraging Industry 4.0 solutions needs interoperability so that different components and applications are able to communicate without any interruption.

India reports 10197 fresh covid cases

India reports 10197 fresh cases, 12134 recoveries & 301 fatalities in the last 24 hrs.

Pfizer's anti-Covid drug can be made by Indian drugmakers without royalties

Under the terms of the head license agreement between Pfizer and Medicines Patent Pool qualified generic drugmakers across the globe that are given sublicenses are eligible to supply PF07321332 in combination with ritonavir to 95 countries, including India.

Mansukh Mandaviya inaugurates Health Pavillion at Trade Fair

Union Health Minister said that the objective of the health pavilion is to create awareness about Non-Communicable Diseases and project the importance of preventive health.